Decipher Mechanisms of Action, Understand Clinical Data & Ignite Partnership Opportunities to Accelerate Your Microbiome Research
Whilst emerging phase 3 data is set to ignite investment and uncover the reality of microbiome-based therapeutics, there remain analytical challenges and translational bottlenecks that the community must come together to overcome, to redefine biopharmaceutical treatment and diagnostic options.
The community is now closer than ever to obtaining an available, approved and commercial microbiome-based therapeutic. This conference joins scientists, clinicians, entrepreneurs and academics, to help assist this success. Persistent hurdles and ongoing challenges with microbiome drug development mean that real-life discussions and learnings are imperative to moving this exciting field forward.
From understanding the microbiome functionality, leveraging lessons from pre-clinical and clinical development, scaling manufacturing processes and regulation hurdles, our discussion will leave you with a holistic view of the European end-to-end development of microbiome therapeutics.
The Microbiome Movement provides the perfect opportunity to actualise the therapeutic promise that the microbiome has provided, by bringing these challenges to the forefront and tackling them head on over three days of extensive content. With the sharing overall aim to commercialise a microbiome-based product.
To know more visit: https://ter.li/rk0suq